TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News

Investing
Why it’s Still Not Too Late to Invest in Marijuana Stocks: What to Do if You Aren’t Sure Which Ones to Buy

Investing
Aphria Inc.: Time to Back Up the Truck?

Investing
5 Reasons Why Shares in Canopy Growth Corp. Could Take Off and Become Scary Big

Investing
How Risky Are Cannabis Stocks in Light of the TMX Group Limited Review?
Investing
Canopy Growth Corp.: How the Stock Could Soar to $20 by the Year’s End

Investing
Are Canada’s Licensed Marijuana Producers at Risk of Becoming Delisted From the TSX?

Investing
Aphria Inc. Plunges ~13.4% in a Day: Time to Throw in the Towel?

Investing
Aphria Inc. Posts 47% EBITDA Growth in Q1 2018, Helped by Lower Costs
Investing
Are Marijuana Stocks Growing Too Fast?

Investing
Projecting Revenues for Canopy Growth Corp. for 2018
